Peterman25
Posted - 17 hours ago
$BEAT On the last earnings call they mentioned that they were getting ready to finalize answers to FDA questions and submit them. Their regulatory affairs person used to be part of the team at the FDA that dealt with these approvals. So, smart hire. Should have excellent knowledge on how to navigate this process. They also mentioned hoping for approval by end of Q2 as that aligned with the end of their study. That’s what I can remember. Hope it helps. Chest pain is the number one reason people go to the ER. According to their last presentation, TAM in the USA is $14B.
TradingtooRetire
Posted - 19 hours ago
$BEAT Wondering if anyone can confirm/shed some light on a few things: 1). Beat hired a regulatory affairs person recently who is now handling the FDA approval, correct? if so, would imagine the timeline they provided for q2 approval should hold a little more weight now? 2). What is the total market opportunity in terms of dollars for this device? thanks in advance
TickerDD_com
Posted - 1 day ago
From 4/9/2024, looking back across 22 Month-Ends for BEAT, Percentage Change of Average Monthly Price had More Positives (55%) while Percentage Change of Average Monthly Volume had All Positives (100%) $BEAT #BEAT #BEATStock #TickerDD https://www.youtube.com/watch?v=WRc2w5T5bRY
BagmanBurns
Posted - 1 day ago
$BEAT still waiting for that FDA news.
Shawn0331
Posted - 6 days ago
$BEAT Come on FDA
VrtcIl
Posted - 1 week ago
$BEAT still gaining momentum towards 2$. The uptrend is supported by consistent increased highs and increased lows, with notable volume signaling increased buying interest. Price: 1.97 Float: 19.5M Short Float: 0.2 % 💰 Dollar Volume: 2.1K ℹ️ USA | Health Information Services
gapureau
Posted - 1 week ago
$ACON This has been quit for too long. Been buying last 2 days below $.29. Should have News soon that should give a boost. Still believe Dr. Thramann is looking to sell this company and concentrate on his other much larger potential company $AUUD. IMO Also: $cero, $beat
InvestingDoc
Posted - 1 week ago
@turuguru @millboy800 This has nothing to do with the current FDA approval or the contemplated initial device. This is simply an AI to diagnose abnormalities on an ECG or VCG. The study does not even use the proprietary transformation matrix $BEAT is proposing for the VCG-12 lead conversion. The improvement in diagnosis of flutter using VCG or 12 lead over a single lead is expected and nothing new. Several other companies are also working in the AI ECG interpretation space - just google search. Each indication (afib, a flutter, heart failure, etc) will require its own FDA approval.
Fookmearse
Posted - 1 week ago
$BEAT 1.50s
millboy800
Posted - 1 week ago
$BEAT interesting low today. It was holding that $2 pretty well but everything went to heck today across the board. Looks like possible correction time.
hehehaha123
Posted - 1 week ago
$BEAT when is FDA approval expected?
net0trader
Posted - 1 week ago
@MaverikIT @Cash4freedom @DonCorleone77 @Wigglyick @RonIsWrong @IsabellaDC @Im_not_Mr_Lebowski anyone here follow $BEAT ? I made a boat load of money that last time BEAT got bought out and I believe this ticket got repurposed and now we have a new BEAT
BagmanBurns
Posted - 1 week ago
$BEAT added more warrants today ? Currently holding 14,500 @ .25. I put my money on FDA approval.
WiganWarrior
Posted - 1 week ago
On watch $TOON $LGVN $OPGN $BEAT
Oil_Pal
Posted - 2 weeks ago
$BEAT Walk it back down to my accumulation zone 🚶♂️🚶♂️🚶♂️
NetworkNewsWire
Posted - 2 weeks ago
BioMedNewsBreaks – $BEAT Presents Key Data in First-Ever Scientific Presentation of Proprietary HeartBeam AI https://ibn.fm/kZG6x
WiganWarrior
Posted - 2 weeks ago
On Watch $GRYP $TOON $OPGN $BEAT
turuguru
Posted - 2 weeks ago
$BEAT In the study, HeartBeam AI with VCG demonstrated a 28% improvement over single-lead ECG in the detection of atrial flutter cases (sensitivity of 91.0% for VCG vs. 71.2% for single-lead ECG) without sacrificing the ability to identify those individuals without atrial flutter (specificity of 98.7% for VCG vs. 96.9% for single-lead ECG)
Stock_Titan
Posted - 2 weeks ago
$BEAT HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias
https://www.stocktitan.net/news/BEAT/heart-beam-presents-positive-results-on-its-artificial-intelligence-588w6ovpuoa1.html
gapureau
Posted - 3 weeks ago
$ACON Few facts: Did 1-for-16 RS 1/2/24, reduced Outstanding shares to approx, 840,000 SP was $2-3 for next 4-6 weeks. Company filed new IPO to raise $3 million in Feb. No coincidence that a few days before closing the SP tanked and instead of less that 2 million shares to raise 3, they issued 5,175,000 @ $.58. (Example of Small cap funding Manipulation at its Best!) As of 3/38/24, 7,153,500 shares outstanding. As of 3/29/24, White Lion Capital is no longer a shareholder (good in my opinion) https://www.sec.gov/Archives/edgar/data/1635077/000119312524082152/d770706dsc13ga.htm Majority of shares owned are at $.58. Buying in low $.30's seems a rather safe bet. Just My Opinion! Also like/own $cero, $beat
Deadman3906
Posted - 03/30/24
$DJT $BEAT $ME $GOOD
millboy800
Posted - 03/29/24
$BEAT this is what your stamp looks like if you guys find it. Ink and a pad is all you need….. just do it!
millboy800
Posted - 03/28/24
$BEAT Hello? FDA? You there? My heart needs your help. Could you look through that stack of papers and move us to the top? Maybe you misplaced the folder? Just use the stamp marked “approved” when you find it. You might even save my life.
gapureau
Posted - 03/27/24
$CERO Phoenix Biotech Acquisition Corp. is the SPAC that CERO was merged into. Raised well over $100 million in IPO. https://www.spacresearch.com/symbol/PBAXU This was original Acquisition/Merger PR. I am very interested in reading the 1st 10-Q filing to see just what it looks like. https://www.cooley.com/news/coverage/2023/2023-06-13-cero-therapeutics-merges-with-phoenix-biotech-acquisition-corp Also like $beat
WiganWarrior
Posted - 4 weeks ago
$BEAT Looking for a bounce back to 2.35 today and then a continuation for the rest of the week
Deadman3906
Posted - 1 month ago
$DJT $BEAT $IT $BE $RT
_www_larval_com_
Posted - 1 month ago
$ZURA -6%[-27%] $NVFY -3%[62%] $BEAT 3%[-6%] $LVTX 3%[14%] $HPCO -3%[-10%] most notable movement into the final minutes of trading.
turuguru
Posted - 1 month ago
$BEAT I understand the drop, no need to hold your position when you can get them cheaper afterwards. Management expects FDA news at the end of Q2. So we have few more months to go and expect the prices to return under 1.5$.
WiganWarrior
Posted - 1 month ago
$BEAT WTF, need a big reversal here